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Abstract
Background: In March 2009, the Task Force for Innovative International Financing for Health Systems
recommended “a health systems funding platform for the Global Fund, GAVI Alliance, the World Bank and others
to coordinate, mobilize, streamline and channel the flow of existing and new international resources to support
national health strategies.” Momentum to establish the Health Systems Funding Platform was swift, with the World
Bank convening a Technical Workshop on Health Systems Strengthening (HSS), and serial meetings organized to
progress the agenda. Despite its potential significance, there has been little comment in peer-reviewed literature,
though some disquiet in the international development community around the scope of the Platform and the
capacity of the partners, which appears disproportionate to the available information.
Methods: This case study uses documentary analysis, participant observation and 24 in-depth interviews to
examine the processes of development and key issues raised by the Platform.
Results: The findings show a fluid and volatile process, with debate over whether ongoing engagement in HSS by
Global Fund and GAVI represents a dilution of organizational focus, risking ongoing support, or a paradigm shift
that facilitates the achievement of targeted objectives, builds systems capacity, and will attract additional resources.
Uncertainty in the development of the Platform reflects the flexibility of the recently formed global health
initiatives, and the instability of donor commitments, particularly in the current financial climate. But implicit in the
conflict is tension between key global stakeholders over defining and ownership of the health systems agenda.
Conclusions: The tensions appear to have been resolved through a focus on national planning, applying
International Health Partnership principles, though the global financial crisis and key personnel changes may yet
alter outcomes. Despite its dynamic evolution, the Platform may offer an incremental path towards increasing
integration around health systems, that has not been previously possible.
Background
On 10 March 2009, Julian Lob-Levyt, (then) Chief
Executive Officer of the GAVI Alliance (GAVI), and
Michel Kazatchkine, Executive Director of The Global
Fund to fight AIDS, Tuberculosis and Malaria (Global
Fund), wrote to Gordon Brown, Prime Minister of the
United Kingdom and Robert Zoellick, President of the
World Bank (WB), co-chairs of the Taskforce on Inno-
vative International Financing for Health Systems. Their
letter presented an ambitious challenge: “It is time to
take a comprehensive approach with the necessary sup-
port from key donors to refocus on all of the health-
related MDGs as a renewed commitment to meeting the
basic health service delivery needs in poor countries. We
are willing and keen to do this.” [1] The response was
swift: within a week, the Task Force meeting had formu-
lated a recommendation to “Establish a health systems
funding platform for the Global Fund, GAVI Alliance,
the World Bank and others to coordinate, mobilize,
streamline and channel the flow of existing and new
international resources to support national health strate-
gies.” [2] In June 2009, the WB hosted a Technical
Workshop on Health Systems Strengthening as a first
response to the Task Force’s call,[3] exploring Health
Systems Strengthening (HSS) with a view to informing
the development of the proposed funding platform.
The shift towards health systems strengthening is one
of the more recent trends in a decade of substantial
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change, as globalization has increasingly impacted on
health and development. The turn of the millennium
brought with it a raft of new initiatives: broad agree-
ment on the Millennium Development Goals refocused
development towards poverty reduction, including speci-
fic health goals for maternal and child health, AIDS,
malaria and tuberculosis [4]. New initiatives offered
innovative partnerships between public and private sec-
tors, specifically addressing the MDGs and other strate-
gies, with new sources of funding from foundations and
philanthropic organizations and an explosion of new
structures and relationships [5]. Multiple new players, in
complex networks of policy influence, have challenged
the constraints of existing aid architecture, demanding
new understandings of global governance [6]. With sub-
stantial progress in targeted programs, there has been
increasing recognition of the need to support health sys-
tems more broadly, with the proposal for a joint funding
platform signaling, for many, a significant shift in global
policy direction [7].
Given this dynamic context, for an initiative of such
potential moment, subsequent debate in the literature has
been parsimonious. Following the Technical Workshop in
Washington, Ruth Levine’s breezy blog [8] pictured a
“three-way marriage” for GAVI, Global Fund and WB that
“brings in the World Health Organization as the maid of
honor”, arguing for a more open process with greater con-
sultation, particularly with potential recipients of the fund-
ing. Despite an initial relative silence, GAVI and WB
websites [9,10] are recently carrying more comprehensive
notes of the process to date. But in the peer-reviewed lit-
erature, reference to the joint platform has been limited,
and largely indirect: questions based on current GAVI and
Global Fund roles and structures and the track record of
WB in health systems [11]; explorations of GAVI’s recent
entry into HSS [12-14] and some tangential consideration
of the implications of the proposed platform for global
governance [15]. The background papers prepared for the
Technical Workshop-accessible from the WB website [3],
but still marked “not available for citation or quotation"-
have only recently begun to translate into the academic lit-
erature [16]. But a statement issued by Action for Global
Health [17] on behalf of some 25 Civil Society Organiza-
tions-including signatories such as the International
Planned Parenthood Federation, Oxfam International and
World Vision International, as well as several national
organizations-suggest levels of anxiety within the develop-
ment community that seem disproportionate to the avail-
able concrete information. Their statement raised
concerns around the respective roles of the partners, ques-
tioning the assumed leadership of WB in preference to the
World Health Organization (WHO), the lack of clarity of
the structure and its relationship to other donor architec-
ture, available funding, the need for a commitment to
universal access to health services and the level of engage-
ment of civil society.
This research seeks to identify and explore the key
issues that have arisen in the development of the Health
Systems Funding Platform, examining their implications
for current directions in development assistance and
global health governance. The case-study recognizes
that this is a dynamic process, and that issues that have
been raised in the research process are in flux: some
issues which have been contentious appear to be
resolved; structures and processes that have been pro-
posed continue to evolve; significant new directions may
yet emerge. Despite this, the research offers an insight
into the contribution of the global health partnerships
to global health policy processes, with their flexibility
and responsiveness, influential leadership and capacity
to engage new paradigms, and their vulnerability to glo-
bal financial and policy trends, and changing preferences
of bilateral donors, and private funding sources.
Methods
This research uses a case-study design [18] to examine
the development of the Health Systems Funding Plat-
form, drawing on discourse analysis to locate the evolu-
tion of the Platform within prevailing debates around
development and global health governance [19]. In seek-
ing to examine contemporaneous issues, the research
faces the challenges of both temporality-tracking change
in a fluid process-and positionality, with ‘outsider’ status
offering the advantages of independence but constraints
in directly accessing more confidential data [20,21].
In order to enhance its rigor [22] and validity [23,24],
the research design triangulates three qualitative
research methods to examine how the progress towards
increasing engagement in HSS, and in particular, the
Health Systems Funding Platform, is constructed by key
stakeholders. The first is a review of the available litera-
ture referring to these processes, including the peer-
reviewed academic literature, reports, media releases
and website postings [25]. Secondly, this has been sup-
plemented by participant observation of the authors and
their colleagues in processes related to HSS (participa-
tion in development of HSS applications, analysis and
evaluation of proposals, membership of relevant boards,
advisory groups and committees, related research) [26].
The third method involved 24 in-depth interviews, with
informants purposively selected to provide insight into
the evolution of the global health initiatives and their
increasing engagement in HSS [22,27]. Informants were
selected from a range of institutional affiliations and
roles or functions, and included officers responsible for
the development of the Platform in each of its partner
organizations. In several cases, institutional affiliations
or roles were multiple: the most relevant has been
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chosen to demonstrate the spread of informants in
Table 1, and served as a focus for the interview. Table 2
provides a timeline of the key events in the development
of the Platform.
The interviews were conducted in two clusters from
September 2009 to November 2010: the first 13 inter-
views were conducted by one researcher (PV), and acted
as framing interviews, using an open format to explore
key issues identified by informants around the recent
development of GAVI and the Global Fund, and their
links to global governance. The second cluster of 11
semi-structured interviews was conducted by a second
researcher (PSH) and used a question guide developed
following the analysis of the framing interviews. The
second interviews explored in more specificity the
engagement of the agencies in HSS and the develop-
ment of proposals for a joint platform for HSS. Inter-
views with selected informants have been subsequently
updated through email and telephone contact.
All interviews, with one exception, were digitally
recorded, and transcribed for analysis. Thematic analysis
of the first thirteen interviews was undertaken manually
by one researcher (MK), and by a second researcher
(PSH) using NVIVO 8 qualitative analysis software pro-
gram (QSR International); differences in themes were
discussed and a consensus reached and the interviews
recoded. The agreed themes were subsequently used in
the analysis of the second set of interviews, and the
resulting analysis structure reviewed by all researchers
[27]. The research proposal was approved by the Institu-
tional Review Board of the Institute of Tropical Medi-
cine, Antwerp (Approval Number 100727100).
Results and Discussion
The presentation of the analysis that follows integrates
the findings obtained through the observation, interviews
and subsequent updates, together with information avail-
able through the scientific literature and web-sites. The
researchers are responsible for the analysis and conclu-
sions, and have previously indicated their support for a
significantly expanded global funding base for health [28].
The shift towards Health Systems Strengthening
Launched in 2001, GAVI had emerged from the Chil-
dren’s Vaccine Initiative as a public-private partnership
that would optimize access to currently underused vac-
cines, strengthen health and immunisation systems in
Table 1 Interview informant matrix
Role/Function Institutional Affiliation
Bilateral Donors Multilateral Agencies GAVI Global Fund Academic Institutions Civil Society Country Partners
Government X X
Board Member X
Senior Management X X X X
X X
X X
X
Program Management X X X X
X X
Policy Analysis X X
X X
Technical Advisors X
X
Table 2 Timeline of key events for the Health Systems
Funding Platform
Date Event
10 March
2009
Letter to Task Force on Innovative International
Financing for Health Systems from GAVI Alliance and
Global Fund.
13 March
2009
Taskforce on Innovative International Financing for
Health Systems Recommendation 9: ‘Establish a health
systems funding platform...’
25-27 June
2009
Health Systems Strengthening: a Technical Workshop
hosted by the World Bank, Global Fund and GAVI
Alliance, Washington DC.
October 2009 Action for Global Health. Delivering for Health Systems
Strengthening: Civil Society Organisations’ Comments on
the Proposed Joint Platform for Health Systems
Strengthening.
26 March
2010
Work Plan for 2010: Health Systems Funding Platform.
June-July
2010
Nepal and Ethiopia complete JANS processes; MOH
Cambodia approves areas of cooperation.
4-5 October
2010
Global Fund 2011-2013 Voluntary Replenishment
Meeting
6 October
2010
GAVI Alliance 2010-2015 Replenishment Process
October 2010 Julian Lob-Levyt resigns as CEO, GAVI Alliance
November
2010
Dagfinn Høybråten voted new Board Chair of GAVI
Alliance
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countries, and make innovative immunisation technol-
ogy available-particularly in developing countries [29].
In December 2005 the Board of the GAVI Alliance
opened a new ‘window’ for HSS initiatives, marking a
substantial broadening of the scope of its funding [30].
This was a distinct paradigm shift for a partnership
barely five years old, created with a specific immunisa-
tion-related mandate. The decision to engage HSS was
contested within the GAVI Alliance Board, but endorsed
by a narrow margin. The Global Fund, launched in 2002
with a focus on the triple threats of HIV/AIDS, tubercu-
losis and malaria [31], later followed GAVI with a single
round of dedicated HSS funding, with similar ambiva-
lence within the Global Fund Board [32]. For GAVI, the
engagement with HSS has had qualified success [12-14],
in part attributed by informants to its containment at
13% of GAVI funds, and its defined “niche focus on
eliminating health system bottlenecks”. In contrast, the
Global Fund’s experiment was described by respondents
as “messy” and “inconsistent”, with a single round of
designated HSS funding, subsequently discontinued and
replaced by national plan based funding. Although up to
35% of Global Fund allocations were reported as
strengthening health systems, the activities were often
diffuse and difficult to define. For advocates of a nar-
rower mandate, this level of health systems allocations
was of concern. Those supportive of health systems
strengthening questioned the extent to which ‘health
systems activities’ contributed only to targeted pro-
grams, rather than strengthening the health system as a
whole. Reviews of health workforce issues raised by Glo-
bal Fund activities marked the tension between addres-
sing its three target diseases and broader health systems
impacts [33]. For the Global Fund, the Platform would
offer some potential resolution: a way to ‘clean up’ its
untidy engagement in HSS-and redress the earlier cri-
tiques of its HSS approach by its own Technical Review
Panel in 2005 [34].
The 2009 proposal for a joint platform for HSS has re-
evoked these same debates within both Boards. Muraskin
[35], in his earlier analysis of GAVI, had identified ten-
sions between those board members for whom the “pri-
macy of immunisation is non-negotiable“ and those-
particularly among the bilateral donors-who advocated
for a broader systems approach in which immunisation
was “integrated with, and subordinated to, broader sys-
tems objectives”. These divisions persist: proponents of
HSS argued that the global health initiatives have picked
the “low hanging fruit”, and now need to extend into
HSS if they are to achieve their own specific mandates.
The GAVI Alliance’s own commissioned research had
increasingly recommended strategies that articulated
with the health system as whole. The Millennium Devel-
opment Goals (MDGs) were seen as defining the urgency
of the overall task, but with the expanded demands of the
MDGs also offering substantial additional capital through
the International Financing Facility for Immunisation
(IFFIm), proposed by the Task Force on Innovative Inter-
national Financing for Health Systems. Here again, fund-
ing pragmatism played a role, with informants arguing
that essential donors would only continue to fund GAVI
and the Global Fund if they were to extend into HSS; if
not, funds were likely to divert to other HSS initiatives.
The opposing factions saw the strategy as risking the per-
ception of competence that both global health initiatives
have built over the past decade. They argued that “dilut-
ing” their mandate through engaging HSS risked their
respective “brands”, and in a compromised donor market,
was gambling with the funds needed for their existing
activities. For those who defined the Global Fund as pri-
marily a funding mechanism, with no brief to extend into
the broader issues of global health policy, managing its
original HSS initiative had already proved problematic.
The internal reviews of the experiment provided little
reassurance. The current Global Fund replenishment
cycle has accentuated these anxieties [36].
But in this debate, as with many policy issues, signifi-
cant heterogeneity is evident among and within the sta-
keholders. While the positions of some organizations
were caricatured by some informants (Levine’s anthro-
pomorphic “marriage” is a humorous example [8]) the
diversity and flexibility of positions within organizations
was evident in perceptions of most interviewees. Infor-
mants remarked on the asymmetry of influence between
stakeholders, with potential recipient countries con-
sulted but with their capacity to shape outcomes limited
until the proposed models had been articulated. Inter-
estingly, the substantial role of individuals in shaping
outcomes was a consistent theme, with the dominance
of the same actors identified by both supporters and
detractors, the impact of their (then imminent) depar-
tures on policy positions weighed. In contrast to the
ambivalence of the GAVI Board, its Secretariat appeared
unequivocally committed to the joint platform. Its Chief
Executive Officer co-signed the original proposal, identi-
fied IFFIm funds as a potential source and secured a
senior appointment and team to progress the agenda.
Leadership within all stakeholder organizations was seen
to determine the options available for consideration,
with modifications of position anticipated with changes
in personnel. Gates himself was reported as explicit in
his opposition to the joint platform proposal put to the
GAVI Board-a position consistent with his technological
focus [37,38]-with his increased personal attendance at
Board meetings interpreted as reinforcing his position.
The “factional” divisions were not as rigidly polarized as
Muraskin [35] would suggest: with three primary part-
ners working on the proposal in separate development
Hill et al. Globalization and Health 2011, 7:16
http://www.globalizationandhealth.com/content/7/1/16
Page 4 of 10
processes, and then meeting with WHO to negotiate
consensus, stakeholders were provided with multiple
points of intervention. As a result of these independent
processes, the content of progress reports put to the
GAVI board was noted as being different from those
put to the Global Fund. More interestingly, key bilateral
donors were said to offer differing positions to each
board-arising in part from their perceptions of the dif-
fering implications of the proposal for the more con-
tained focus of GAVI, and the more polyvalent
engagement of Global Fund-and another to the meet-
ings of the WB. Changes within the United States politi-
cal administration were reflected in their evolving
position; perceptions of the appropriateness of applying
IFFIm funding to this proposal qualified the position of
some bilateral donors, with the Japanese indicating a
willingness to contribute directly to the HSS proposal.
In particular, WHO’s heavy dependence on Global Fund
funding for implementation of country HIV/AIDS pro-
grams, generated tensions within WHO itself, with fac-
tional positions that paralleled the opposing perspectives
within the Global Fund Board. The failure to include
WHO in the initial conceptualization of the Platform [1]
fed into broader agency politics around WB’s contested
claim over leadership in health systems policy more
broadly, and health systems strengthening specifically
[39]. WHO’s ready acceptance of the role of ‘facilitator’
for the Platform was seen by some respondents as con-
ceding its designated ‘technical’ role in health systems
strengthening [39]; by others as a pragmatic recognition
that, unlike the other three partners, it had limited
financial resources of its own to contribute to the
Platform.
Developing the Platform: structure and definition
Platform funding
The Task Force for Innovative International Financing
for Health Systems met in a climate of economic opti-
mism: in early 2009, the innovative financing mechan-
isms championed in their report were expected to offer
an additional $10 billion a year [2]. Financial expecta-
tions for the Platform were initially high: “flash floods of
funds” was the description of one informant. Despite
the resistance of some stakeholders to the creation of
further structures for global health, an environment of
ambitious optimism had been created by the resurgence
of corporate philanthropy, with its substantial mobiliza-
tion of development resources through the global health
initiatives, and the demonstrable achievements of the
AIDS antiretroviral treatment roll-out. Health advocates
were arguing for the transformation of the Global Fund
into a “Global Health Fund” [40], or together with GAVI
Alliance, into a “global fund for the health MDGs” [41].
Not surprisingly the concepts were conflated in the
minds of several informants, who spoke of the “global
platform” for HSS, and in one case imagined a “global
fund for everything”. The chastened context of the global
financial crisis has changed much of that expectation, the
IFFIm funding more modest than anticipated and not
unambiguously available to the Platform. Both GAVI and
Global Fund informants were quick to put the Platform
in perspective, noting the failure of the donor community
to embrace proposals for a global fund for health: “It
looks like, in the financial barrel at the moment, there’s
not going to be big up-front, front-loaded resources.” As
reiterated on GAVI’s website: “The Platform is not a glo-
bal pool of funds: funds will still flow from the participat-
ing financers-currently the GAVI Alliance, the Global
Fund and the World Bank.” [10]
Platform governance
Issues of governance-and the impact of the proposed
platform on global health governance-were integral to
the discourses around the joint platform. The imprima-
tur of the Task Force on Innovative International Finan-
cing for Health Systems had associated the Platform
with a global challenge-the health MDGs-and the “pool-
ing of resources at the global level... funds from existing
traditional DAH [Development Assistance for Health]
and innovative sources” [2]. Concerns around the inter-
nal governance of the Platform were coloured by these
global connotations, with old fault lines opening up, and
deep tensions reactivated. Action for Global Health’s
position was to “oppose the World Bank adopting a lea-
dership role at global or national level in the proposed
joint platform... In contrast to the World Bank, the
WHO is the lead UN agency on health and already has
the global mandate to lead on health policy and health
systems strengthening” [17]. One key informant envi-
saged the possibility that the Platform had the potential
to “define the health systems agenda and the priorities,
with substantial funding behind it... a de facto institu-
tion... created in parallel to the World Health Assembly
but [with] even less sense of accountability than the
World Health Assembly itself.” In the absence of more
nuanced detail for the proposed platform, debate risked
devolving to organizational caricatures and threats
amplified by historical divisions.
Yet the same simplifications work positively, enabling
respondents within the platform partners to conceive of
a “collaborative division of labour” [39] with WHO and
WB represented as maintaining complementary posi-
tions: “It’s a coordination of roles, and put simply, for
me, the Ministry of Health internationally is WHO... the
World Bank is more the Ministry of Finance.” In these
constructions of the Platform, any anxiety that the lack
of a local in-country GAVI or Global Fund presence
would automatically lead to WB paradigms dominating
the implementation of the Platform were countered by a
Hill et al. Globalization and Health 2011, 7:16
http://www.globalizationandhealth.com/content/7/1/16
Page 5 of 10
division of influence: WHO would retain its technical
and normative functions; WB its sustainable financing
policy and budget frameworks. Characterising their rela-
tive strengths had already been used in justifying the
partnership, with GAVI’s competence in immunisation
seen as a logical bridge to a broader MDG4 orbit of
responsibility. Shakow’s Global Fund-World Bank HIV/
AIDS Programs Comparative Advantage Study [42] had
conceded any lead role in health systems strengthening
to the WB, neatly allocating to the Global Fund the stra-
tegic financial and technical focus on its three nomi-
nated diseases. In an extrapolation of this role division,
discussions around the Platform suggested that between
the three agencies, the ‘health system’ could be covered:
GAVI extending its coverage to include a broader
Maternal and Child Health agenda, the Global Fund
adding the neglected tropical diseases and global epi-
demics to its brief, and WB covering generic finance
and systems issues.
Yet this convenient role differentiation has papered
over other differences between the partners. Their gov-
ernance structures differ, with the World Bank’s Board
accountable to its 187 country members, and in particu-
lar, its major contributors. Its structure, rooted in the
1944 Bretton Woods agreements [43], contrasts with the
comparable flexibility of the GAVI and Global Fund
Boards, with their differing mixes of public and private
sector (both industry and civil society) stakeholders. The
World Bank’s resource allocation processes lack the
responsiveness of GAVI and Global Fund processes, and
changes to health financing cannot be made without
implications for the Bank as a whole. This has con-
strained WB participation in current models for the
Platform. The three hold differing approaches to the
sustainability of funding, essential to the long term ima-
gining of the Platform, with the World Bank reluctant
to depend on development assistance for permanent
increases in recurrent expenditure [44] and Global Fund
arguing for sustained international support for recipients
[45], but facing the challenges that this brings in its
replenishment cycles [36].
Resistance to the joint platform within the boards of
both GAVI Alliance and the Global Fund reportedly
coalesced around perceptions of “dilution of mandate”
and an erosion of focus and efficacy with the broadening
of their commitment. Attention was drawn to the dis-
tinctive resource allocation processes maintained by the
three partners, with some scepticism that WB would be
able to adopt the more participatory processes of both
GAVI and Global Fund. Yet in the models currently
being promoted, the proposal for a common application
form for both GAVI and Global Fund has to some
extent accommodated this, with WB only engaged in
one option of the two tracks proposed, not engaged
with GAVI and Global Fund in the harmonisation of
existing HSS funding, nor in the common application
form process. It will contribute to the total available
HSS funding through national planning processes, but
will maintain its current evaluation and approval proce-
dures. The adoption of IHP’s Joint Assessment of
National Strategies (JANS) tool [46] as a basis for fund-
ing applications has provided the single most significant
mechanism of alignment within the Platform, and with
the strong existing linkage of JANS and IHP to the Aid
Effectiveness Agenda doing much to neutralise criti-
cisms. Interestingly, in March 2010, while the platform
partners, or informants within WHO or IHP itself did
not canvas the use of JANS or the platform’s alignment
with IHP as concrete propositions during interviews, the
functions of the platform were consistently conceptua-
lised in terms of the aid effectiveness principles, with
one informant speculating that “I know that some peo-
ple view the platform as the missing part of IHP, where
IHP was supposed to come with the promise of money
and the platform will be that.”
Platform scope
Yet beyond the uncertainty around the quantum of
funding available, and its implications for governance
options, there has been a particular but charged debate
around the scope of the proposal: whether it applies to
Health Systems or Health Systems Strengthening. The
Task Force recommended a “health systems funding
platform” [2], though the IFFIm funding is clearly
described as a mechanism to “support health systems
strengthening” [47]. The World Bank hosted the Technical
Workshop on Health System Strengthening in June 2009,
and a month late a joint meeting was convened in Geneva
to discuss the “Joint Programming and Funding Platform
for Health System Strengthening” [48]. Action for Global
Health’s critique is of the proposed “Joint Platform for
Health Systems Strengthening” [17], though the eventual
formal title seems to have been resolved as the Health
Systems Funding Platform [10].
Health systems strengthening continues to be used
within documentation in descriptions of the objectives
of the platform, though individual informants from both
partners and critics of the platform were emphatic that
the platform was not a health systems strengthening
platform, but a health systems funding platform, “and
that distinction is quite important because there has
actually been a whole battle around that”. The website
of the Technical Workshop appears to allude to that
contention:
“The workshop proved very useful in drawing out a
diversity of views on Health Systems and Health Sys-
tems Strengthening. A couple of points became clear
- that while there are a variety of HS frameworks
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they tend to have common elements; there was little
enthusiasm for developing a new “common” HS fra-
mework or for more “debate” among frameworks.”[3]
Yet this lack of enthusiasm does not imply that con-
sensus around HSS had already been reached. The ten-
sions implicit in the Workshop agenda seem to reflect a
deeper conflict over the “territory of health systems
strengthening” and by implication, health systems. In
part, there was resistance to the “academic agenda” con-
structed in the Workshop program: the background
papers comprehensively mapped the diversity of health
systems approaches, and explored potential frameworks
for HSS [3]. Yet this exploration itself prompted con-
cern: respondents who had expected the Technical
Workshop to focus on the practical mechanics of the
platform argued that the program “doesn’t talk just
about harmonising funding floats, it talks about defining
health systems, defining priorities of health systems,
defining the frameworks of health systems, defining
health systems strengthening”. For reasons that are inte-
gral to the development of the concepts underlying
health systems, the Technical Workshop could not be
the locus for that defining to occur.
Health Systems and the Platform: evolution and
resolution
The importance of health systems is not contested.
From its World Health Report 2000 [49], WHO has re-
iterated its health systems focus in a Framework for
Action [50], linking it implicitly to the re-launch of its
Primary Health Care initiative [51]. Health systems
obstacles to achieving the MDGs have been identified
[7] with a call for a global focus on health systems
reform [52,53]. Evidence of synergy between global
health initiatives and health systems has been documen-
ted [54] and health systems strengthening re-interpreted
through systems theory [55,56]. Yet the scepticism
expressed by Marchal et al. [57] around the ‘meaning’ of
health systems strengthening is germane to the defining
of the Platform. They argue that global health initiatives
(not exclusively GAVI Alliance and the Global Fund), by
tying health systems strengthening to their particular
mandates, shift from a “comprehensive discourse to a
selective practice": on the one hand focussing on specific
health systems obstacles to their own narrow objectives;
on the other, labelling any capacity-building activity as
‘systems strengthening’ [57].
In the case of the Health Systems Funding Platform,
the tensions around nomenclature can be understood in
terms of metonymy, where one element of a concept
may be seen to stand for the whole. Beginning from the
frame of immunisation (GAVI) or AIDS, Tuberculosis
and Malaria (Global Fund), health systems strengthening
evokes a health system, but one that is constrained-
arguably distorted-by this limited framing. The tension,
then, lies between two possible representations of the
health system: the system constructed from a HSS pre-
mise, differing substantially from the health system
framed from a more comprehensive perspective. In
short, the Platform had the potential to redefine the
health systems agenda as a whole, and not simply the
interface with its own composite programs. With the
promise of substantial funding, and its structure embra-
cing four dominant development agencies and open to
additional partners, the perceived risks were significant.
If it was to extend its brief to embrace MDGs 4, 5 and
6, and beyond, as the Task Force had envisaged, reshap-
ing the global development approach to health systems,
the Platform needed a different point of departure. In
the words of the old joke: “if that’s where you want to
go, you’d better not be starting from here!”
Conclusions
This debate, constructed in terms of its threats to global
health governance, has been largely resolved by the Plat-
form at the level of the local-the national-health system.
The Health Systems Funding Platform has shifted the
point of engagement from the global, with its focus on
partner relationships, to country level, essentially using
IHP+ as the local umbrella for its commitment to one
national plan and one financial management framework,
harmonizing and aligning their results and monitoring
and evaluation plans. The simplification of transaction
costs, application and funding mechanisms remains a
goal: a common application form will apply for submis-
sions to either GAVI or Global Fund, and countries hav-
ing completed their Joint Assessment of National
Strategies will be able to seek funding in line with their
National Health Plan [58], though funding initially will
proceed through separate grant agreements. The pro-
posed process takes advantages of structures largely in
place, though the pragmatics of changing procedures
and synchronising funding cycles in each of the partners
mean that in the short term, achieving harmonisation is
the goal, rather than complete integration [59]. It does
accommodate the necessary variance expected between
country applications, and allows for differing local struc-
tures (Sector Wide Approaches or other funding pool
mechanisms) and alignment with country planning
cycles.
The resolution of the structure of the Health Systems
Funding Platform speaks both to the flexibility of the
global health initiatives, and the volatility of debate
around the health systems agenda. Reflecting on the
development of the Platform, the elements that com-
prise the final structure have largely been present at all
stages of its evolution-articulated both in the positions
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of the partners, and of their critics: the recognised need
for a health systems approach, the commitment to the
Paris Principles and to reduced transaction costs in
development planning, the links to the MDGs, the utility
of IHP+ engagement with countries. Using Fidler’s ana-
logy of open source codes [60], it is as though repacka-
ging of the available elements has become possible,
emerging from contested forums-both internal and
external-with the reframing of Health Systems stitching
the whole concept together [61]. The resultant Platform
is neither the threat to global health governance that
some had envisaged, nor merely the “modest” proce-
dural alignment posed as a possible outcome by one of
the partner informants.
The proposal, as it currently stands, is an elegant but
diminished solution to the challenge of maintaining pro-
gress towards integration in the face of limited available
resources, and the logistics of implementation. It clearly
articulates with the progressive movement towards align-
ment of development assistance and harmonisation of
processes, though the initial JANS pilot will include only
four to five countries. The engagement with IHP+ is
mutually beneficial, making the advantages of the IHP+
principles more concrete to recipients, but providing a
structure for engagement and a filter for the Platform by
identifying governments committed to collaborative pro-
cesses. The statement of protest has been withdrawn from
the Action for Global Health website. Yet the evidence to
date is that the Platform’s emergent form continues to be
the product of the ongoing interaction with the network
of elements to which it is linked: the pool of partners,
their leadership, the global economic situation, trends in
development assistance and in global health governance.
Cumulative changes could cheat it of its potential. The
IHP+, to which the Platform’s fortunes are shackled, is
itself vulnerable, with disquiet around its progress to date
and the political linkage through its initial champion, Gor-
don Brown, now attenuated [62,63]. Julian Lob-Levyt has
resigned from his position at the GAVI Alliance, and part-
ners are already negotiating a ‘post-Julian’ calendar [64].
The failure of the replenishment cycles to meet expecta-
tions [36] has re-focused attention on core mandates for
GAVI and Global Fund. In reporting that suggests that
GAVI “will not expand its remit to engage more fully with
revitalising health-care systems”, the new chair of its
Board, Dagfinn Høybråten is quoted as saying “the eco-
nomic climate is tight right now so we have to maintain
our focus on delivering the vaccines that developing coun-
tries are demanding” [65]. Global Fund is reported as
wanting to be explicit in its containment of the funding
allocation to HSS. World Bank processes have been mini-
mally changed by the Platform. The global financial crisis
has already impacted on the commitments of several bilat-
eral donors, and offers no certain future.
But with global health initiatives multiplying and
fragmenting to address specific targeted agendas, the
Health Systems Funding Platform offers a significant,
initial move in the opposite direction, towards synth-
esis. It may not be the imagined outcome of that ambi-
tious letter to the Taskforce, with its possibility of
merging funding streams into a single channel, focus-
ing on health systems at the heart of efforts to achieve
MDGs 4, 5 and 6. Yet it constitutes positive progress,
a realistic option in the current global political and
economic context. Demonstrable results from the first
cycle of applications should encourage additional fund-
ing: perhaps enough to galvanise a concerted and sub-
stantial investment in health systems. The path to the
increasing integration of health systems support could
prove to be incremental. And we should be able to get
there from here.
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